Psychedelics and the Self: A Conversation with James Fadiman (Episode #242)

Generally, individuals with a history of psychotic episodes, schizophrenia, bipolar disorder, or other serious mental health conditions are advised against taking high doses of psychedelics. However, some research suggests bipolar individuals seeking help might find benefit during depressive phases.

While both are psychedelics, psilocybin is often described as a 'kinder' and more 'emotionally gentle' experience, potentially due to its plant-based origin. LSD is sometimes perceived as 'colder' and more 'powerful'. A key difference is the duration: LSD trips typically last 8-12 hours, while psilocybin trips are shorter, around 4-6 hours.

A guide, or 'sitter', plays a crucial role in ensuring safety and facilitating a positive experience. They are a sober companion who can offer reassurance, support, and help navigate difficult moments without interfering unnecessarily. Their presence can prevent strongly negative experiences and aid in processing the insights gained.

Set refers to your mental attitude, intentions, and psychological state before taking a psychedelic. Setting involves the physical environment, the people you are with, and the overall situation. Both are critical, as psychedelics are highly sensitive to these factors. Your current life situation also significantly impacts the experience.

Dosages vary widely: 25 micrograms can produce mild psychedelic effects, 50-100 micrograms are considered concert or museum doses, 100-200 micrograms are suited for therapeutic work with a professional, and 200-400 micrograms can lead to profound transcendent or mystical experiences.

MDMA is not a classic psychedelic because it doesn't cause you to go beyond your own identity. Instead, it creates a safe inner space where traumatic memories can be processed objectively and moved into conventional memory, rather than dominating the present. It is typically administered in a therapeutic environment with guides.

Yes, according to some experiences, taking 'just enough' to scramble ordinary reality or potentiate fixation on problems, without enough to 'fly clear' of them, can lead to an unpleasant experience. It might amplify negative states without providing the perspective needed for transcendence.

Reported benefits include performing better at work, having more successful interactions, generating new ideas, increased physical stamina, and enjoying time with family more. Users often forget they've taken a dose, indicating a lack of overt psychedelic effects.

Microdosing, like other psychedelics, is generally considered not addictive. Many individuals find they naturally reduce the frequency of use over time as they gain desired benefits, suggesting it does not lead to compulsive use.

While often beneficial for depression, microdosing might be contraindicated for individuals with anxiety disorders. The increased arousal associated with microdosing could potentially exacerbate existing anxiety-like symptoms for some people.